Development and characterisation study of liposomes-encapsulated piroxicam
Keywords:
Proliposomes, Liposomes, Piroxicam, Encapsulation, Particle size, Transmission electron microscopyAbstract
The objective of present work was to develop a novel liposomes-based drug delivery system for a lipophilic nonsteroidal anti-inflammatory drug, piroxicam. The system was prepared using proliposomes method and optimised for different preparation parameters including type of proliposomes, concentration of drug, duration of hydration and type of particle size reduction treatment used. All prepared liposomal samples were extensively characterized for their drug-entrapment and size profile using various in-vitro techniques. Present work showed that the most optimum formulation (Pro-lipoTM Duo; 12mg piroxicam per gram ProlipoTM; 10 hours hydration time) produced highest amount of actual drug been entrapped in liposomes (800.4 mg/g ProlipoTM) with a satisfactory entrapment efficiency of 15.36%. This formulation had also produced liposomal samples with a homogenous (polydispersity index = 0.45) and small particle size (359.95nm). Extrusion technique was found to cause significant reduction in drug-entrapment and size profile of drug-loaded liposomes. A 4-weeks storage study showed that drug-entrapment and size profile of liposomal samples were stable in both refrigerated and room temperature. Electron microscopy revealed that prepared liposomal samples were spherical-shaped and showed concentric lamellae. In conclusion, present work successfully demonstrated a simple, reproducible and practical method of preparation for liposomes-encapsulated p
References
Gulati M, Grover M, Singh S, Singh M,
Lipophilic drug derivatives in
liposomes. Int. J. Pharm., 165, 129–168.
Agarwal R, Katare OP, Vyas SP, 2001.
Preparation and in vitro evaluation of
liposomal/niosomal delivery systems for
antipsoriatic drug dithranol. Int. J. Pharm.,
, 43–52.
Hens AG, Romero JMF. 2006. Analytical
methods for the control of liposomal
delivery systems. Trend Anal. Chem.,
(2), 167-178.
Vasudevan DM, Sreekumari S, 2005.
Phospholipids. In: Textbook of
Biochemistry For Medical Students, 4th
Ed., Jaypee Brothers Medical Publishers,
New Delhi, pp. 76-77.
Baudrimonta I, Murnb M, Betheder AM,
Guilcher J, Creppy EE, 1995. Effect of
piroxicam on the nephrotoxicity induced by
ochratoxin A in rats. Toxicology, 147, 1-4.
Starek M, Krzek J, 2009. A review of
analytical techniques for determination of
oxicams, nimesulide and nabumetone.
Talanta, 77, 925–942.
Tagliati CA, Kimura E. Nothenberg MS.,
Santos S, Oga S, 1999. Pharmacokinetic
profile and gastric effect of zinc-piroxicam
in rats. Gen. Pharmacol., 33, 67–71.
Matos C, Lima JLC, Reis S, Lopes, A.,
Bastos, M., 2004. Interaction of antiinflammatory drugs with EPC liposomes:
calorimetric study in a broad concentration
range. Biophys. J., 86, 946–954.
Lopes LB, Scarpa MV, Pereira NL, Oliveira
LC, Oliveira AG. 2006. Interaction of
sodium diclofenac with freeze-dried soya
phosphatidylcholine and unilamellar
liposomes. Braz. J. Pharm. Sci., 42(4), 497-
Vemuri S, Rhodes CT, 1995. Preparation
and characterization of liposomes as
therapeutic delivery systems: a review.
Pharm. Acta Helv., 70, 95-111.
Perrett S, Golding M, Williams WP. 1991.
A simple method for the preparation of
liposomes for pharmaceutical applications:
characterization of the liposomes. J. Pharm.
Pharmacol., 43, 54–161.
Turanek J, Zaluska D, Neca J, 1997. Linkup
of a fast protein liquid chromatography
system with a stirred thermostated cell for
sterile preparation of liposomes by the
proliposome–liposome method: Application
to encapsulation of antibiotics, synthetic
peptide immunomodulators and a
photosensitizer. Anal. Biochem., 249, 131–
Shahiwala A, Misra A. 2002. Studies in
topical application of niosomally entrapped
nimesulide. J. Pharm. Pharmaceut. Sci.,
(3), 220-225.
Ling SSN. 2004. Investigation of liposomes
for oral delivery of peptidomimetic drugs.
Ph.D Thesis. Universiti Sains Malaysia,
Malaysia.
Lucchetti G, Assogna G, Bagnato P. 1996.
Liposomal piroxicam formulations. US
Patent 5505960, 9 Apr.
Singh A, Lawson GE, Shivakrupa R,
Johnson BT, Blumenthal R, Puri A. 2007.
Piroxicam entrapped in head-group
polymerized liposomes inhibits
proliferation of IC2 mast cells in vitro.
Mater. Res. Soc. Symp. Proc., 1019, FF02-
Martin FJ. 1990. Pharmaceutical
manufacturing of liposomes. In: Specialized
Drug Delivery Systems: Manufacturing and
Production Technology, Marcel Dekker,
New York, pp. 267-316.
Alpar OH, Bamford JB, Walters V. 1981.
The in vitro incorporation and release of
hydroxocobalamin by liposomes. Int. J.
Pharm., 7, 349-351.
Fa N, Lins L, Courtoy PJ, Dufrêne Y, Van
Der Smissen P, Brasseur R, Tyteca D,
Mingeot-Leclercq M.-P. 2007. Decrease of
elastic moduli of DOPC bilayers induced by
a macrolide antibiotic, azithromycin.
Biochim Biophys Acta, 1768, 1830–1838.
Fresta M, Villari A, Puglisi G, Cavallaro G.
5-Fluorouracil: various kina of loaded
liposomes: encapsulation efficiency, storage
stability and fusogenic properties. Int. J.
Pharm., 99, 145-156.
Sharma A, Sharma US. 1997. Liposomes in
drug delivery: progress and limitations. Int.
J. Pharm., 154, 123-140.
Elorza B, Elorza MA, Sainz MC, Chantres
JR. 1993. Análysis of the particle size
distribution and the internal volume of
liposomal preparations. J. Pharm. Sci.,
(11), 1160-1163.
Chen HM, Langer R. 1998. Oral particle
delivery: status and future trends. Adv.
Drug Del. Rev., 34(2-3), 339-350.
Segota S, Tezak D. 2006. Spontaneous
formation of vesicles. Adv. Colloid Interfac.
, 51–75.
Betageri GV, Jenkins SA, Parsons DL.
Preparation of liposomes. In:
Liposome Drug Delivery Systems,
Technomic Publishing Company,
Lancaster, pp. 1-24.
Elhissi AMA, Faizi M, Naji WF, Gill HS,
Taylor KMG. 2007. Physical stability and
aerosol properties of liposomes delivered
using an air-jet nebulizer and a novel
micropump device with large mesh
apertures. Int. J. Pharm., 334, 62–70.
Talsma H, Van Steebergen MJ, Salemink
PJM, Crommelin JA. 1991. The
cryopreservation of liposomes. 1. a
differential scanning calorimetry study of
the thermal behaviour of a liposomes
dispersion containing mannitol during
freezing/thawing. Pharm. Res., 8(8), 1021-
